CHIARAVALLOTI, AGOSTINO
CHIARAVALLOTI, AGOSTINO
Dipartimento di Medicina sperimentale e clinica
Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: A prospective study
2022-01-01 Fernandes, Mariana; Manfredi, Natalia; Aluisantonio, Lavinia; Franchini, Flaminia; Chiaravalloti, Agostino; Izzi, Francesca; Di Santo, Simona; Schillaci, Orazio; Mercuri, Nicola Biagio; Placidi, Fabio; Liguori, Claudio
Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early 18F-FCH PET/CT?
2015-01-01 Di Biagio, D.; Chiaravalloti, A.; Tavolozza, M.; Abbatiello, P.; Schillaci, O.
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: Molecular imaging with 123I-MIBG
2012-01-01 Chiaravalloti, A.; Stefani, A.; Tavolozza, M.; Pierantozzi, M.; Di Biagio, D.; Olivola, E.; Di Pietro, B.; Stampanoni, M.; Danieli, R.; Simonetti, G.; Stanzione, P.; Schillaci, O.
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: Molecular imaging with 123I-FP-CIT SPECT
2011-01-01 Schillaci, O.; Chiaravalloti, A.; Pierantozzi, M.; Di Pietro, B.; Koch, G.; Bruni, C.; Stanzione, P.; Stefani, A.
Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease
2014-01-01 Chiaravalloti, A.; Stefani, A.; Fiorentini, A.; Lacanfora, A.; Stanzione, P.; Schillaci, O.
Factors affecting 18F FDOPA standardized uptake value in patients with primary brain tumors after treatment
2015-01-01 Chiaravalloti, A.; Fiorentini, A.; Villani, V.; Carapella, C.; Pace, A.; Di Pietro, B.; Di Russo, C.; Palumbo, B.; Floris, R.; Schillaci, O.
Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/18F-FDG-PET Study
2023-01-01 Bonomi, C. G.; Chiaravalloti, A.; Camedda, R.; Ricci, F.; Mercuri, N. B.; Schillaci, O.; Koch, G.; Martorana, A.; Motta, C.
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases
2021-01-01 Sala, Arianna; Caminiti, Silvia Paola; Presotto, Luca; Pilotto, Andrea; Liguori, Claudio; Chiaravalloti, Agostino; Garibotto, Valentina; Frisoni, Giovanni Battista; D’Amelio, Marcello; Paghera, Barbara; Schillaci, Orazio; Mercuri, Nicola; Padovani, Alessandro; Perani, Daniela
Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario
2020-01-01 Vanni, Gianluca; Pellicciaro, Marco; Materazzo, Marco; Bruno, Valentina; Oldani, Chiara; Pistolese, Chiara Adriana; Buonomo, Chiara; Caspi, Jonathan; Gualtieri, Paola; Chiaravalloti, Agostino; Palombi, Leonardo; Piccione, Emilio; Buonomo, Oreste Claudio
Molecular and Metabolic Imaging of Castration-Resistant Prostate Cancer: State of Art and Future Prospects
2022-01-01 Filippi, L.; Chiaravalloti, A.; Basile, P.; Schillaci, O.; Bagni, O.
Reconstruction-dependent differences in brain [18F]FDG PET: a large-scale same-acquisition comparison of Q.Clear and VUE Point FX
2026-01-01 Chiaravalloti, A.; Di Biagio, D.; D'Ascenzo, N.; Urbano, N.; Martorana, A.; Schillaci, O.
Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship
2015-01-01 Chiaravalloti, A.; Schillaci, O.
Thalamic 123I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression
2012-01-01 Schillaci, O.; Chiaravalloti, A.; Di Pietro, B.; Stefani, A.
WIDEN: A tool for medical image management in multicenter clinical trials
2014-01-01 Chauvie, S.; Biggi, A.; Stancu, A.; Cerello, P.; Cavallo, A.; Fallanca, F.; Ficola, U.; Gregianin, M.; Guerra, U. P.; Chiaravalloti, A.; Schillaci, O.; Gallamini, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: A prospective study | 1-gen-2022 | Fernandes, Mariana; Manfredi, Natalia; Aluisantonio, Lavinia; Franchini, Flaminia; Chiaravalloti, Agostino; Izzi, Francesca; Di Santo, Simona; Schillaci, Orazio; Mercuri, Nicola Biagio; Placidi, Fabio; Liguori, Claudio | |
| Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early 18F-FCH PET/CT? | 1-gen-2015 | Di Biagio, D.; Chiaravalloti, A.; Tavolozza, M.; Abbatiello, P.; Schillaci, O. | |
| Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: Molecular imaging with 123I-MIBG | 1-gen-2012 | Chiaravalloti, A.; Stefani, A.; Tavolozza, M.; Pierantozzi, M.; Di Biagio, D.; Olivola, E.; Di Pietro, B.; Stampanoni, M.; Danieli, R.; Simonetti, G.; Stanzione, P.; Schillaci, O. | |
| Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: Molecular imaging with 123I-FP-CIT SPECT | 1-gen-2011 | Schillaci, O.; Chiaravalloti, A.; Pierantozzi, M.; Di Pietro, B.; Koch, G.; Bruni, C.; Stanzione, P.; Stefani, A. | |
| Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease | 1-gen-2014 | Chiaravalloti, A.; Stefani, A.; Fiorentini, A.; Lacanfora, A.; Stanzione, P.; Schillaci, O. | |
| Factors affecting 18F FDOPA standardized uptake value in patients with primary brain tumors after treatment | 1-gen-2015 | Chiaravalloti, A.; Fiorentini, A.; Villani, V.; Carapella, C.; Pace, A.; Di Pietro, B.; Di Russo, C.; Palumbo, B.; Floris, R.; Schillaci, O. | |
| Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/18F-FDG-PET Study | 1-gen-2023 | Bonomi, C. G.; Chiaravalloti, A.; Camedda, R.; Ricci, F.; Mercuri, N. B.; Schillaci, O.; Koch, G.; Martorana, A.; Motta, C. | |
| In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases | 1-gen-2021 | Sala, Arianna; Caminiti, Silvia Paola; Presotto, Luca; Pilotto, Andrea; Liguori, Claudio; Chiaravalloti, Agostino; Garibotto, Valentina; Frisoni, Giovanni Battista; D’Amelio, Marcello; Paghera, Barbara; Schillaci, Orazio; Mercuri, Nicola; Padovani, Alessandro; Perani, Daniela | |
| Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario | 1-gen-2020 | Vanni, Gianluca; Pellicciaro, Marco; Materazzo, Marco; Bruno, Valentina; Oldani, Chiara; Pistolese, Chiara Adriana; Buonomo, Chiara; Caspi, Jonathan; Gualtieri, Paola; Chiaravalloti, Agostino; Palombi, Leonardo; Piccione, Emilio; Buonomo, Oreste Claudio | |
| Molecular and Metabolic Imaging of Castration-Resistant Prostate Cancer: State of Art and Future Prospects | 1-gen-2022 | Filippi, L.; Chiaravalloti, A.; Basile, P.; Schillaci, O.; Bagni, O. | |
| Reconstruction-dependent differences in brain [18F]FDG PET: a large-scale same-acquisition comparison of Q.Clear and VUE Point FX | 1-gen-2026 | Chiaravalloti, A.; Di Biagio, D.; D'Ascenzo, N.; Urbano, N.; Martorana, A.; Schillaci, O. | |
| Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship | 1-gen-2015 | Chiaravalloti, A.; Schillaci, O. | |
| Thalamic 123I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression | 1-gen-2012 | Schillaci, O.; Chiaravalloti, A.; Di Pietro, B.; Stefani, A. | |
| WIDEN: A tool for medical image management in multicenter clinical trials | 1-gen-2014 | Chauvie, S.; Biggi, A.; Stancu, A.; Cerello, P.; Cavallo, A.; Fallanca, F.; Ficola, U.; Gregianin, M.; Guerra, U. P.; Chiaravalloti, A.; Schillaci, O.; Gallamini, A. |